
Biogen
OrganizationHeard in 4 episodes across 3 shows since Jul 2026
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases. Founded in 1978, the company is well-known for its treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease.
Episodes
4
across 3 shows
First heard
Jul 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
2
2
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 2 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 2 |
What experts have said about Biogen
1 statement · 1 positive
Biogen raised its full-year revenue outlook.
“The company raised its revenue outlook for the year.”
Open the episode · Humana Sinks; Ford Climbs; Biogen BeatListen at 2:19
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Biogen, newest first
- Oct 7, 2026
Cramer tests consumer resilience, AI defenses and Wall Street targetsMad Money w/ Jim CramerOct 7, 2026 - Oct 6, 2026
Inherited dementia tests identity, family and hopeThis Podcast Will Kill YouOct 6, 2026 - Jul 29, 2026
Corporate earnings reveal sharp divide between healthcare and automotive sectorsStock MoversJul 29, 2026 - Jul 13, 2026
SK Hynix tumbles on AI concerns while Biogen and TriCo riseStock MoversJul 13, 2026